全文获取类型
收费全文 | 73085篇 |
免费 | 4607篇 |
国内免费 | 277篇 |
专业分类
耳鼻咽喉 | 1150篇 |
儿科学 | 2188篇 |
妇产科学 | 1360篇 |
基础医学 | 7903篇 |
口腔科学 | 1508篇 |
临床医学 | 7122篇 |
内科学 | 15171篇 |
皮肤病学 | 1186篇 |
神经病学 | 7007篇 |
特种医学 | 2579篇 |
外国民族医学 | 5篇 |
外科学 | 12844篇 |
综合类 | 876篇 |
一般理论 | 97篇 |
预防医学 | 5932篇 |
眼科学 | 1526篇 |
药学 | 4678篇 |
中国医学 | 109篇 |
肿瘤学 | 4728篇 |
出版年
2023年 | 371篇 |
2022年 | 292篇 |
2021年 | 1722篇 |
2020年 | 987篇 |
2019年 | 1630篇 |
2018年 | 1899篇 |
2017年 | 1379篇 |
2016年 | 1411篇 |
2015年 | 1575篇 |
2014年 | 2409篇 |
2013年 | 3371篇 |
2012年 | 5089篇 |
2011年 | 5283篇 |
2010年 | 2933篇 |
2009年 | 2567篇 |
2008年 | 4660篇 |
2007年 | 4932篇 |
2006年 | 4779篇 |
2005年 | 4762篇 |
2004年 | 4463篇 |
2003年 | 4097篇 |
2002年 | 3796篇 |
2001年 | 575篇 |
2000年 | 487篇 |
1999年 | 604篇 |
1998年 | 656篇 |
1997年 | 556篇 |
1996年 | 480篇 |
1995年 | 524篇 |
1994年 | 502篇 |
1993年 | 424篇 |
1992年 | 377篇 |
1991年 | 383篇 |
1990年 | 308篇 |
1989年 | 292篇 |
1988年 | 284篇 |
1987年 | 264篇 |
1986年 | 272篇 |
1985年 | 366篇 |
1984年 | 430篇 |
1983年 | 360篇 |
1982年 | 514篇 |
1981年 | 485篇 |
1980年 | 452篇 |
1979年 | 205篇 |
1978年 | 272篇 |
1977年 | 255篇 |
1976年 | 200篇 |
1975年 | 219篇 |
1973年 | 183篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
91.
Joseph M. Kindler Michelle Guo Joshua Baker Shana McCormack Saro H. Armenian Babette S. Zemel Mary B. Leonard Sogol Mostoufi-Moab 《Journal of bone and mineral research》2022,37(4):794-803
Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a common therapy for pediatric hematologic malignancies. With improved supportive care, addressing treatment-related late effects is at the forefront of survivor long-term health and quality of life. We previously demonstrated that alloHSCT survivors had increased adiposity, decreased lean mass, and lower bone density and strength, 7 years (median) from alloHSCT compared to their healthy peers. Yet it is unknown whether these deficits persist. Our longitudinal study characterized changes in muscle and bone over a period of 3.4 (range, 2.0 to 4.9) years in 47 childhood alloHSCT survivors, age 5–26 years at baseline (34% female). Tibia cortical bone geometry and volumetric density and lower leg muscle cross-sectional area (MCSA) were assessed via peripheral quantitative computed tomography (pQCT). Anthropometric and pQCT measurements were converted to age, sex, and ancestry-specific standard deviation scores, adjusted for leg length. Muscle-specific force was assessed as strength relative to MCSA adjusted for leg length (strength Z-score). Measurements were compared to a healthy reference cohort (n = 921), age 5–30 years (52% female). At baseline and follow-up, alloHSCT survivors demonstrated lower height Z-scores, weight Z-scores, and leg length Z-scores compared to the healthy reference cohort. Deficits in MCSA, trabecular volumetric bone density, and cortical bone size and estimated strength (section modulus) were evident in survivors (all p < 0.05). Between the two study time points, anthropometric, muscle, and bone Z-scores did not change significantly in alloHSCT survivors. Approximately 15% and 17% of alloHSCT survivors had MCSA and section modulus Z-score < −2.0, at baseline and follow-up, respectively. Furthermore, those with a history of total body irradiation compared to those without demonstrated lower MCSA at follow-up. The persistent muscle and bone deficits in pediatric alloHSCT survivors support the need for strategies to improve bone and muscle health in this at-risk population. © 2022 American Society for Bone and Mineral Research (ASBMR). 相似文献
92.
93.
Nuno Rui Paulino Pereira Paul T. Ogink Olivier Q. Groot Marco L. Ferrone Francis J. Hornicek C.N. van Dijk J.A.M. Bramer Joseph H. Schwab 《The spine journal》2019,19(1):144-156
Background Context
Postoperative morbidity may offset the potential benefits of surgical treatment for spine metastatic disease; hence, risk factors for postoperative complications and reoperations should be taken into considerations during surgical decision-making. In addition, it remains unknown whether complications and reoperations shorten these patients' survival.Purpose
We aimed to describe and identify factors associated with having a complication within 30 days of index surgery as well as factors associated with having a subsequent reoperation. Furthermore, we assessed the effect of 30-day complications and reoperations on the patients' postoperative survival, as well as described neurologic changes after surgery.Study Design
Retrospective cohort study.Patient Sample
We included 647 patients 18 years and older who had surgery for metastatic disease in the spine between January 2002 and January 2014 in one of two affiliated tertiary care centers.Outcome Measures
Our primary outcomes were complications within 30 days after surgery and reoperations until final follow-up or death.Methods
We used multivariate logistic regression to identify risk factors for 30-day complications and reoperations. We used the Cox regression analysis to assess the effect of postoperative complications and reoperations on survival.Results
From 647 included patients, 205 (32%) had a complication within 30 days. The following variables were independently associated with 30-day complications: lower albumin levels (odds ratio [OR]: 0.69, 95% confidence interval [CI]=0.49–0.96, p=.021), additional comorbidities (OR=1.42, 95% CI=1.00–2.01, p=.048), pathologic fracture (OR=1.41, 95% CI=0.97–2.05, p=.031), three or more spine levels operated upon (OR=1.64, 95% CI=1.02–2.64, p=.027), and combined surgical approach (OR=2.44, 95% CI=1.06–5.60, p=.036). One hundred and fifteen patients (18%) had at least one reoperation after the initial surgery; prior radiotherapy (OR=1.56, 95% CI=1.07–2.29, p=.021) to the spinal tumor was independently associated with reoperation. 30-day complications were associated with worse survival (hazard ratio [HR]=1.40, 95% CI=1.17–1.68, p<.001), and reoperation was not significantly associated with worse survival (HR=0.80, 95% CI=0.09–1.00, p=.054). Neurologic status worsened in 42 (6.7%), remained stable in 445 (71%), and improved in 140 (22%) patients after surgery.Conclusions
Three or more spine levels operated upon and prior radiotherapy should prompt consideration of a preoperative plastic surgery consultation regarding soft tissue coverage. Furthermore, if time allows, aggressive nutritional supplementation should be considered for patient with low preoperative serum albumin levels. Surgeons should be aware of the increase in complications in patients presenting with pathologic fracture, undergoing a combined approach, and with any additional preoperative comorbidities. Importantly, 30-day complications were associated with worsened survival. 相似文献94.
95.
Peffault de Latour Rgis Huynh Lynn Ivanova Jasmina I. Totev Todor Bilginsoy Mehmet Antin Joseph Roy Anuja Duh Mei Sheng 《Annals of hematology》2020,99(4):743-752
Annals of Hematology - This study assessed treatment patterns and healthcare resource utilization (HRU) of patients with severe aplastic anemia (SAA) with insufficient response to immunosuppressive... 相似文献
96.
Murphree Catherine R. Olson Sven R. DeLoughery Thomas G. Shatzel Joseph J. 《Journal of thrombosis and thrombolysis》2020,49(4):602-605
Journal of Thrombosis and Thrombolysis - Thrombotic Microangiopathy (TMA) is a heterogeneous collection of syndromes that encompasses TTP, HUS, and other processes characterized by... 相似文献
97.
98.
99.
100.
Joseph O. Lloyd Kim I. Chisholm Beatrice Oehle Martyn G. Jones Bright N. Okine Adnan AL-Kaisy Giorgio Lambru Stephen B. McMahon Anna P. Andreou 《Neurotherapeutics》2020,17(4):1973
Single-pulse transcranial magnetic stimulation (sTMS) of the occipital cortex is an effective migraine treatment. However, its mechanism of action and cortical effects of sTMS in migraine are yet to be elucidated. Using calcium imaging and GCaMP-expressing mice, sTMS did not depolarise neurons and had no effect on vascular tone. Pre-treatment with sTMS, however, significantly affected some characteristics of the cortical spreading depression (CSD) wave, the correlate of migraine aura. sTMS inhibited spontaneous neuronal firing in the visual cortex in a dose-dependent manner and attenuated l-glutamate-evoked firing, but not in the presence of GABAA/B antagonists. In the CSD model, sTMS increased the CSD electrical threshold, but not in the presence of GABAA/B antagonists. We first report here that sTMS at intensities similar to those used in the treatment of migraine, unlike traditional sTMS applied in other neurological fields, does not excite cortical neurons but it reduces spontaneous cortical neuronal activity and suppresses the migraine aura biological substrate, potentially by interacting with GABAergic circuits.Electronic supplementary materialThe online version of this article (10.1007/s13311-020-00879-6) contains supplementary material, which is available to authorized users.Key Words: Migraine, transcranial magnetic stimulation, GABA, glutamate, cortex 相似文献